Literature DB >> 6888709

Significance testing of many variables. Problems and solutions.

K Abt.   

Abstract

More than one variable of interest in pharmaco-EEG studies is the rule rather than the exception. The many-variables situation may arise from several types of EEG variables and/or from repeated measurements of these variables through time. In many cases, multivariate analysis techniques are not suitable for application. As an alternative, the analyst usually applies individual (univariate) tests for all variables and/or time points. This significance testing of many variables causes problems because of the so-called 'alpha-inflation', i.e. the inflation of the probability for the 'error of the first kind' to reject a null hypothesis although it is valid. To counteract this effect (which invalidates the significance levels used for hypothesis testing), various procedures have been proposed some of which are discussed in the present paper. All procedures involve so-called 'alpha-adjustments', and two procedures are based upon the assumption that the investigator demands that at least a given percentage of all individual null hypotheses considered will be rejected or are not valid, respectively.

Mesh:

Substances:

Year:  1983        PMID: 6888709     DOI: 10.1159/000117937

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  9 in total

Review 1.  Quantified neurophysiology with mapping: statistical inference, exploratory and confirmatory data analysis.

Authors:  F H Duffy; K Jones; P Bartels; M Albert; G B McAnulty; H Als
Journal:  Brain Topogr       Date:  1990       Impact factor: 3.020

2.  Inter- and intra-individual probability maps in EEG cartography by use of nonparametric Fisher tests.

Authors:  P Etévenon; A Bertaut; F Mitermite; F Eustache; J Lepaisant; B Lechevalier; E Zarifian
Journal:  Brain Topogr       Date:  1989 Fall-Winter       Impact factor: 3.020

3.  Influence of ACTH 4-10 and unilateral ECT on primary and secondary memory in depressive patients.

Authors:  S O Frederiksen; G d'Elia; F Holsten
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

4.  Probability mapping: power and coherence analyses of cognitive processes.

Authors:  P Rappelsberger; H Petsche
Journal:  Brain Topogr       Date:  1988       Impact factor: 3.020

5.  Brain and human pain: topographic EEG amplitude and coherence mapping.

Authors:  A C Chen; P Rappelsberger
Journal:  Brain Topogr       Date:  1994       Impact factor: 3.020

6.  The hyperventilation-induced ischaemia model in human neuropharmacology: neurophysiological and psychometric studies of aniracetam and 3-OH aniracetam.

Authors:  V Kraaier; A C van Huffelen; G H Wieneke
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

7.  l-fenfluramine and haloperidol in rats: a qEEG comparison.

Authors:  C Sebban; B Tesolin; A Shvaloff; B Lemaitre-Guardiola
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

8.  Brainstem evoked potentials in panic disorder.

Authors:  V J Knott; D Bakish; J Barkley
Journal:  J Psychiatry Neurosci       Date:  1994-07       Impact factor: 6.186

9.  EEG spectral coherence data distinguish chronic fatigue syndrome patients from healthy controls and depressed patients--a case control study.

Authors:  Frank H Duffy; Gloria B McAnulty; Michelle C McCreary; George J Cuchural; Anthony L Komaroff
Journal:  BMC Neurol       Date:  2011-07-01       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.